Literature DB >> 35199691

Silent Myocardial Infarction and Acute Multiorgan Failure in a COVID-19 Patient: A Case Report.

Nischit Baral1, Andrea Montalbano2, Ashiya Khan1, Mehak Qureshi1, Pankaj Luitel3.   

Abstract

Silent myocardial infarction or unrecognized myocardial infarction has increased prevalence in elderly population with increased cardiovascular risk factors. However, its prevalence in COVID-19 patients is not well-known. A 77-year-old Caucasian male with COVID-19 pneumonia, presented with silent ST-segment elevation myocardial infarction, diabetic ketoacidosis and multiorgan failure. He underwent cardiac catheterization and drug eluting stent placement in the ostial right coronary artery with safety protocol. He was discharged to extended-care-facility in stable condition. This is a first case report of silent ST-segment elevation myocardial infarction in a patient presenting with COVID-19. In patients with COVID-19, acute myocardial infarction should be ruled out even when asymptomatic, especially in older patients. Prompt intervention using safety protocol is life-saving.

Entities:  

Keywords:  case reports; COVID-19; myocardial infraction; ST elevation myocardial infarction.

Mesh:

Year:  2021        PMID: 35199691      PMCID: PMC9107826          DOI: 10.31729/jnma.6933

Source DB:  PubMed          Journal:  JNMA J Nepal Med Assoc        ISSN: 0028-2715            Impact factor:   0.556


  8 in total

Review 1.  Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: a review of the literature.

Authors:  Paul Valensi; Luc Lorgis; Yves Cottin
Journal:  Arch Cardiovasc Dis       Date:  2011-03-26       Impact factor: 2.340

2.  The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome.

Authors:  Marco Ranucci; Andrea Ballotta; Umberto Di Dedda; Ekaterina Bayshnikova; Marco Dei Poli; Marco Resta; Mara Falco; Giovanni Albano; Lorenzo Menicanti
Journal:  J Thromb Haemost       Date:  2020-05-06       Impact factor: 5.824

Review 3.  Cardiovascular complications in COVID-19.

Authors:  Brit Long; William J Brady; Alex Koyfman; Michael Gottlieb
Journal:  Am J Emerg Med       Date:  2020-04-18       Impact factor: 2.469

4.  COVID-19-convalescence phase unmasks a silent myocardial infarction due to coronary plaque rupture.

Authors:  Carsten Tschöpe; Mohammad Sherif; Markus S Anker; Dominik Geisel; Titus Kuehne; Sebastian Kelle
Journal:  ESC Heart Fail       Date:  2021-01-06

5.  Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection.

Authors:  Lina Ma; Sanjaya K Sahu; Marlene Cano; Vasanthan Kuppuswamy; Jamal Bajwa; Ja'Nia McPhatter; Alexander Pine; Matthew Meizlish; George Goshua; C-Hong Chang; Hanming Zhang; Christina Price; Parveen Bahel; Henry Rinder; Tingting Lei; Aaron Day; Daniel Reynolds; Xiaobo Wu; Rebecca Schriefer; Adriana M Rauseo; Charles W Goss; Jane A O'Halloran; Rachel M Presti; Alfred H Kim; Andrew E Gelman; Charles Dela Cruz; Alfred I Lee; Phillip Mudd; Hyung J Chun; John P Atkinson; Hrishikesh S Kulkarni
Journal:  bioRxiv       Date:  2021-02-23

6.  COVID-19: consider cytokine storm syndromes and immunosuppression.

Authors:  Puja Mehta; Daniel F McAuley; Michael Brown; Emilie Sanchez; Rachel S Tattersall; Jessica J Manson
Journal:  Lancet       Date:  2020-03-16       Impact factor: 79.321

7.  Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.

Authors:  I Hamming; W Timens; M L C Bulthuis; A T Lely; G J Navis; H van Goor
Journal:  J Pathol       Date:  2004-06       Impact factor: 7.996

8.  Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction.

Authors:  Anas Hamadeh; Ali Aldujeli; Kasparas Briedis; Kristen M Tecson; Jorge Sanz-Sánchez; Montazar Al Dujeili; Ammar Al-Obeidi; Jose Luís Diez; Remigijus Žaliūnas; Robert C Stoler; Peter A McCullough
Journal:  Am J Cardiol       Date:  2020-07-03       Impact factor: 2.778

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.